EVOGENE LTD. Cost Of Sales
EVOGENE LTD. (EVGN) reported Cost Of Sales of $4.09 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Expense Statement
ifrs-full:CostOfSales · last filed 2026-03-26
| Period end | Cost Of Sales 6 month | Cost Of Sales 6 month as first filed | Cost Of Sales 12 month | Cost Of Sales 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $4.09M 20-F · filed 2026-03-26 | |||
| 2025-06-30 | $1.65M 6-K · filed 2025-09-30 | |||
| 2024-12-31 | $2.38M 20-F · filed 2026-03-26 | $2.68M 20-F · filed 2025-03-27 | ||
| 2024-06-30 | $646.00K 6-K · filed 2025-09-30 | $847.00K 6-K · filed 2024-09-16 | ||
| 2023-12-31 | $1.49M 20-F · filed 2026-03-26 | $1.69M 20-F · filed 2024-03-28 | ||
| 2023-06-30 | $783.00K 6-K · filed 2024-09-16 | |||
| 2022-12-31 | $909.00K 20-F · filed 2025-03-27 | |||
| 2022-06-30 | $425.00K 6-K · filed 2023-09-13 | |||
| 2021-12-31 | $767.00K 20-F · filed 2024-03-28 | |||
| 2021-06-30 | $399.00K 6-K · filed 2022-09-07 | |||
| 2020-12-31 | $574.00K 20-F · filed 2023-03-30 | |||
| 2020-06-30 | $153.00K 6-K · filed 2021-08-31 | |||
| 2019-12-31 | $334.00K 20-F · filed 2022-03-31 | |||
| 2019-06-30 | $172.00K 6-K · filed 2020-09-15 | |||
| 2018-12-31 | $1.45M 20-F · filed 2021-04-02 | |||
| 2017-12-31 | $2.85M 20-F · filed 2020-04-27 | |||
| 2016-12-31 | $5.64M 20-F · filed 2019-04-29 | |||
| 2015-12-31 | $8.26M 20-F · filed 2018-03-30 |